Advanced NanoBiomed Research, Volume 5, Issue 12, December 2025.Overview of the use of silica nanoparticles in vaccines against pathogens. Different kinds of vaccines against infectious diseases are currently using solid or mesoporous silica nanoparticles in their formulation. Silica microparticles and nanoparticles (SiNPs) have been studied as vehicles for vaccines.
Noe Juvenal Mendoza‐Ramírez +3 more
wiley +1 more source
Clinical progress note: Varicella Zoster
Journal of Hospital Medicine, Volume 20, Issue 12, Page 1348-1350, December 2025.Abstract Varicella Zoster virus (VZV) is the etiologic agent responsible for varicella and herpes zoster (shingles). Nonimmune children and adults acutely infected with VZV typically experience a vesicular and pruritic rash that progresses from the face and trunk and generalizes to the extremities, accompanied by an oral enanthem along with symptoms of
Sirey Zhang, Adam L. Hersh, T. W. Jones
wiley +1 more source
A Case of Genital and Extragenital Warts Unresponsive to Immunotherapy Using Measles, Mumps, Rubella Vaccine. [PDF]
Int Med Case Rep J, 2023 Achdiat PA +3 more
europepmc +1 more source
Barriers to measles mumps rubella vaccine acceptance in the three southern border provinces of Thailand. [PDF]
Clin Exp Vaccine Res, 2023 Sirithammaphan U +2 more
europepmc +1 more source
Illness after measles-mumps-rubella vaccination.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 1993 To provide accurate information on the common sequelae of measles-mumps-rubella (MMR) vaccination and to compare post-vaccine symptoms in children vaccinated at 13 and 15 months.Prospective cluster randomized controlled trial.Twenty-two family practices in southwestern Ontario.All 376 infants who were due to receive MMR vaccine in the next year, 253 ...
T R, Freeman, M A, Stewart, L, Turner
openaire +1 more source
Can We Justify Intralesional Immunotherapy with Measles-mumps-rubella Vaccine for Recalcitrant Facial Warts? [PDF]
Oman Med J, 2022 Al-Mendalawi MD.
europepmc +1 more source
Efficacy of Intralesional Measles Mumps Rubella Vaccine in the Treatment of Verruca Vulgaris: An Interventional Study. [PDF]
Cureus, 2023 Surani AS, Un R, Marfatia Y.
europepmc +1 more source
Measles, Mumps, Rubella Vaccine (PRIORIX): Recommendations of the Advisory Committee on Immunization Practices - United States, 2022. [PDF]
MMWR Morb Mortal Wkly Rep, 2022 Krow-Lucal E +5 more
europepmc +1 more source
Intralesional Measles-Mumps-Rubella Vaccine for Genital Warts: Report of two cases with a review of literature. [PDF]
Sultan Qaboos Univ Med J, 2022 Al-Qassabi AM, Al-Farsi F.
europepmc +1 more source
Mumps vaccine effectiveness of a 3rd dose of measles, mumps, rubella vaccine in school settings during a mumps outbreak -- Arkansas, 2016-2017. [PDF]
Public Health Pract (Oxf), 2023 Guo A +10 more
europepmc +1 more source